Richard J. Tajak
Director Financiero/CFO en Fresenius Kabi Pharmaceuticals Holding LLC .
Perfil
Richard J.
Tajak is currently the EVP, Chief Financial & Accounting Officer at Fresenius Kabi Pharmaceuticals Holding LLC since 2011 and the Chief Financial & Operating Officer at NantPharma LLC since 2014.
Previously, he served as the Chief Financial Officer at NantKwest, Inc. from 2016 to 2018.
He also held positions as the Chief Financial Officer & Executive Vice President at APP Pharmaceuticals, Inc. and as the Senior Vice President-North American Finance at Astellas Pharmaceuticals SA. Mr. Tajak completed his undergraduate degree and MBA from the University of Notre Dame.
Cargos activos de Richard J. Tajak
| Empresas | Cargo | Inicio |
|---|---|---|
Fresenius Kabi Pharmaceuticals Holding LLC
 Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Director Financiero/CFO | 28/02/2011 |
NantPharma LLC
 NantPharma LLC Pharmaceuticals: MajorHealth Technology Part of NantWorks LLC, NantPharma LLC is a company that manufactures injectable pharmaceutical products. The company is based in Lincolnshire, IL. | Director Financiero/CFO | 01/01/2014 |
Antiguos cargos conocidos de Richard J. Tajak.
| Empresas | Cargo | Fin |
|---|---|---|
| IMMUNITYBIO, INC. | Director Financiero/CFO | 11/06/2018 |
| Astellas Pharmaceuticals SA | Corporate Officer/Principal | - |
APP Pharmaceuticals, Inc.
 APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Director Financiero/CFO | - |
Formación de Richard J. Tajak.
| University of Notre Dame | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
APP Pharmaceuticals, Inc.
APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Health Technology |
Fresenius Kabi Pharmaceuticals Holding LLC
Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Health Technology |
| Astellas Pharmaceuticals SA | |
NantKwest, Inc.
 NantKwest, Inc. BiotechnologyHealth Technology NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA. | Health Technology |
NantPharma LLC
NantPharma LLC Pharmaceuticals: MajorHealth Technology Part of NantWorks LLC, NantPharma LLC is a company that manufactures injectable pharmaceutical products. The company is based in Lincolnshire, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Richard J. Tajak
